not tagged
not tagged
#ims2022 | brings up the importance of continuous assessment of risk beyond r-iss. other key clinical variables like early relapse or drug refractoriness define a functional hr disease that should be considered for treatment decisions, trial design and analysis #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma